iplex entered the market for short stature in 2008 and was a BUST! , that is a fact.
In the months of sales before being stopped by the lawsuit,sales were so embarrassing low that many here didn't even realize Iplex was on the market for more than 9 months. 2 years to get manuft up, better start soon !
REPOST again ( liar got caught) Insmed plans limited launch in EU in 2016 • jad9000
by terry_insm • 5 hours ago
Informed Insmed and biotech investors know the company's plan. Faced with factual info yesterday,jad9000 then posted: .....jad9000 • "A formal launch does not preclude sales prior to full fledged marketing campaign revenues in 2015 !"
Her answer is not surprising, be it regulatory... trading.... or facts, jad9000 simply makes upcht.
Its not even funny anymore,she is obviously `sic
"jad9000 • Jul 22, 2014 ( FOURTEEN! )) 9:24 AM "They are ramping up to begin sales sooner than later - likely small quantities by yearend, We will have both FDA and EU approvals by the end of Q3."
"jad9000 • Feb 11, 2015 " So, 2016 would be a market of 17,500 at a price of around $50,000 annually or slightly under $900 million. All of the EU would be then be around 35,000 cases at $50,000 annually, or $1.75 billion. Then we add in CF, Japan with their 35,000 cases (40,000 by 2016) and the year after the US market around 35,000 (also 40,000 by 2016). That's quite a few billions of dollars by the end of 2016"
jad9000 • Sep 18, 2014 = Fyi, I just reamed their investor relations people for not publicizing these things as well as the illegal manipulation of the offering. The criminals cost us tens of millions on that offering and should be sued to recuperate those losses. They have no defense - they were caught red handed. There is no denial about the crime, only about the level of the losses shareholders took
10 Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares
11 Percent of Class Represented by Amount in Row 9
Shire is not planning to give insmed iplex they have no interest in the drug they are about arikace